Introduction Transplant recipients are at risk of post-transplant lymphoproliferative disease (PTLD). in plasma at PTLD analysis; while the tumor was not restricted at analysis, kappa restriction was present 5 years later on when the PTLD relapsed. Conversation Plasma markers of B-cell dysfunction are frequent following transplantation and associated with poor EBV control. These irregular markers… Continue reading Introduction Transplant recipients are at risk of post-transplant lymphoproliferative disease (PTLD).